Postdoctoral Fellow, University of Toronto
Dr. Ashwin Seetharaman holds a Ph.D. in Molecular Genetics from the University of Toronto, Canada. As a graduate student, he elucidated the biological function of a novel gene called madd-4, in the tiny nematode C. elegans, which has now gained wide interest in the field of neurodevelopment. Presently, as a postdoctoral research fellow in the Boone/Moffat labs, his work involves unraveling genetic interaction networks underlying human disease using the CRISPR-Cas9 genome editing technology. Particularly, a major focus of his research is to elucidate the biological role of NGLY1 in human cells using genetic and functional genomic approaches.
It's time to rethink what the medical profession considers a 'rare disease'
Feb 28, 2019 03:08 am UTC| Insights & Views Health
International Rare Disease Day is upon us. People around the world spend Feb. 28 raising awareness about the impact that diseases with low prevalence have on patients and their families. The day also marks the passing...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects